Chronotherapeutic Effects of Atorvastatin Administration on Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial
Advances in Pharmacology and Therapeutics Journal · 16.06.2026
DOI: 10.18502/aptj.v5i4.21762 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Advances in Pharmacology and Therapeutics Journal, online erschienen am 16.06.2026. Verfasst von Sepideh Tavanaei Fard und 5 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is commonly associated with dyslipidemia and increased cardiovascular risk. Atorvastatin, a widely used statin, effectively improves lipid profiles. This study aimed to compare the effects of morning versus evening administration of atorvastatin on lipid parameters in patients with T2DM. Materials and Methods: This randomized controlled trial enrolled 76 patients with T2DM, randomly assigned to receive Atorvastatin 40 mg either in the morning (n=38) or evening (n=38) for 4 weeks. Fasting serum triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured at baseline and post-treatment. Baseline lipid values were included as covariates in ANCOVA to compare post-treatment levels between groups.
Results
Atorvastatin significantly improved lipid profiles in both groups: LDL-C, TG, and TC decreased (P
Zitieren
APA
Fard, S. T., Moazezi, Z., Hosseini, A., Shirafkan, H., Andevari, A. N., & Meftah, N. (2026). Chronotherapeutic Effects of Atorvastatin Administration on Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial. Advances in Pharmacology and Therapeutics Journal. https://doi.org/10.18502/aptj.v5i4.21762
Vancouver
Fard ST, Moazezi Z, Hosseini A, Shirafkan H, Andevari AN, Meftah N. Chronotherapeutic Effects of Atorvastatin Administration on Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial. Advances in Pharmacology and Therapeutics Journal. 2026. doi:10.18502/aptj.v5i4.21762
BibTeX
@article{Fard2026,
author = {Fard, Sepideh Tavanaei and Moazezi, Zoleika and Hosseini, Akramasadat and Shirafkan, Hoda and Andevari, Ali Nosrati and Meftah, Neda},
title = {Chronotherapeutic Effects of Atorvastatin Administration on Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial},
journal = {Advances in Pharmacology and Therapeutics Journal},
year = {2026},
doi = {10.18502/aptj.v5i4.21762}
}
EUVIMED